Why is Bliss GVS Pharma falling/rising?

As of 04-Jul, Bliss GVS Pharma Ltd's stock price is currently at 156.35, reflecting a decrease of 0.15 (-0.1%). The stock has underperformed its sector today by 0.61% and has experienced a trend reversal, falling after two consecutive days of gains. In terms of returns, the stock has shown a positive performance over the past month with an increase of 18.04%, while it has declined by 5.04% year-to-date. Despite a strong annual return of 37.94%, the company has reported a significant drop in profits by 19.5% over the past year, which may be contributing to investor concerns. Additionally, the stock is trading at a premium compared to its peers, and the company has declared negative results for the last three consecutive quarters, which could be impacting investor sentiment.
In the broader market context, Bliss GVS Pharma's short-term performance of -0.45% over the past week contrasts with the Sensex, which has declined by 0.74% during the same period. This indicates that while the stock is facing challenges, it is still performing relatively better than the benchmark in the short term. However, the falling investor participation, as evidenced by a 17.65% drop in delivery volume, suggests a lack of confidence among investors. The company's low debt-to-equity ratio and fair valuation may not be enough to offset the negative sentiment stemming from its recent financial performance and the absence of domestic mutual fund investment, which could signal a lack of confidence in the stock's future growth potential.